• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在面临巨大需求的情况下确保连续性肾脏替代治疗的可持续性:COVID-19 大流行带来的经验教训。

Ensuring Sustainability of Continuous Kidney Replacement Therapy in the Face of Extraordinary Demand: Lessons From the COVID-19 Pandemic.

机构信息

Division of Nephrology, Department of Medicine, National University Hospital, Singapore; Yong Loo Lin School of Medicine, National University of Singapore, Singapore.

Yong Loo Lin School of Medicine, National University of Singapore, Singapore; Cardiothoracic Intensive Care Unit, Department of Cardiac, Thoracic & Vascular Surgery, National University Hospital, Singapore.

出版信息

Am J Kidney Dis. 2020 Sep;76(3):392-400. doi: 10.1053/j.ajkd.2020.05.008. Epub 2020 Jun 4.

DOI:10.1053/j.ajkd.2020.05.008
PMID:
32505811
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7272152/
Abstract

With the exponential surge in patients with coronavirus disease 2019 (COVID-19) worldwide, the resources needed to provide continuous kidney replacement therapy (CKRT) for patients with acute kidney injury or kidney failure may be threatened. This article summarizes subsisting strategies that can be implemented immediately. Pre-emptive weekly multicenter projections of CKRT demand based on evolving COVID-19 epidemiology and routine workload should be made. Corresponding consumables should be quantified and acquired, with diversification of sources from multiple vendors. Supply procurement should be stepped up accordingly so that a several-week stock is amassed, with administrative oversight to prevent disproportionate hoarding by institutions. Consumption of CKRT resources can be made more efficient by optimizing circuit anticoagulation to preserve filters, extending use of each vascular access, lowering blood flows to reduce citrate consumption, moderating the CKRT intensity to conserve fluids, or running accelerated KRT at higher clearance to treat more patients per machine. If logistically feasible, earlier transition to intermittent hemodialysis with online-generated dialysate, or urgent peritoneal dialysis in selected patients, may help reduce CKRT dependency. These measures, coupled to multicenter collaboration and a corresponding increase in trained medical and nursing staffing levels, may avoid downstream rationing of care and save lives during the peak of the pandemic.

摘要

随着全球 2019 冠状病毒病(COVID-19)患者数量的指数级增长,为急性肾损伤或肾衰竭患者提供连续肾脏替代治疗(CKRT)所需的资源可能受到威胁。本文总结了可以立即实施的现有策略。应根据不断变化的 COVID-19 流行病学和常规工作量,每周预先进行多中心 CKRT 需求预测。应量化并获取相应的消耗品,并从多个供应商处实现来源多样化。应相应加快供应采购速度,以便积累数周的库存,并进行行政监督,以防止机构之间不成比例的囤积。通过优化回路抗凝以保留过滤器、延长每个血管通路的使用时间、降低血流量以减少柠檬酸盐消耗、适度调整 CKRT 强度以节省液体、或运行更高清除率的加速 KRT 以每台机器治疗更多患者,可以提高 CKRT 资源的使用效率。如果在物流上可行,早期过渡到在线生成透析液的间歇性血液透析,或在选定患者中紧急进行腹膜透析,可能有助于减少对 CKRT 的依赖。这些措施加上多中心合作和相应增加经过培训的医疗和护理人员配备水平,可能避免在大流行高峰期进行下游护理配给并拯救生命。

相似文献

1
Ensuring Sustainability of Continuous Kidney Replacement Therapy in the Face of Extraordinary Demand: Lessons From the COVID-19 Pandemic.在面临巨大需求的情况下确保连续性肾脏替代治疗的可持续性:COVID-19 大流行带来的经验教训。
Am J Kidney Dis. 2020 Sep;76(3):392-400. doi: 10.1053/j.ajkd.2020.05.008. Epub 2020 Jun 4.
2
Estimating Shortages in Capacity to Deliver Continuous Kidney Replacement Therapy During the COVID-19 Pandemic in the United States.估算美国在 COVID-19 大流行期间连续肾脏替代疗法提供能力短缺。
Am J Kidney Dis. 2020 Nov;76(5):696-709.e1. doi: 10.1053/j.ajkd.2020.07.005. Epub 2020 Jul 28.
3
Urgent Peritoneal Dialysis in Patients With COVID-19 and Acute Kidney Injury: A Single-Center Experience in a Time of Crisis in the United States.《COVID-19 合并急性肾损伤患者的紧急腹膜透析:美国危机时期的单中心经验》。
Am J Kidney Dis. 2020 Sep;76(3):401-406. doi: 10.1053/j.ajkd.2020.06.001. Epub 2020 Jun 11.
4
Impending Shortages of Kidney Replacement Therapy for COVID-19 Patients.新冠患者肾脏替代治疗即将面临短缺
Clin J Am Soc Nephrol. 2020 Jun 8;15(6):880-882. doi: 10.2215/CJN.05180420. Epub 2020 Apr 28.
5
Acute Kidney Injury and Special Considerations during Renal Replacement Therapy in Children with Coronavirus Disease-19: Perspective from the Critical Care Nephrology Section of the European Society of Paediatric and Neonatal Intensive Care.儿童 2019 冠状病毒病急性肾损伤及肾脏替代治疗的特殊考虑:来自欧洲儿童和新生儿重症监护学会重症肾脏病学组的观点。
Blood Purif. 2021;50(2):150-160. doi: 10.1159/000509677. Epub 2020 Jul 14.
6
Regional Citrate Anticoagulation for Continuous Kidney Replacement Therapy With Calcium-Containing Solutions: A Cohort Study.局部枸橼酸抗凝在含钙溶液行连续性肾脏替代治疗中的应用:一项队列研究。
Am J Kidney Dis. 2021 Oct;78(4):550-559.e1. doi: 10.1053/j.ajkd.2021.01.017. Epub 2021 Mar 30.
7
COVID-19 and Impending Shortage of Haemodialysis Facilities due to the Rising Incidence of Acute Kidney Injury Requiring Renal Replacement Therapy.2019冠状病毒病与急性肾损伤发病率上升导致需要肾脏替代治疗的血液透析设施即将短缺
J Coll Physicians Surg Pak. 2020 Jun;30(6):89-90. doi: 10.29271/jcpsp.2020.Supp1.S89.
8
Comparison of different anticoagulation strategies for renal replacement therapy in critically ill patients with COVID-19: a cohort study.比较 COVID-19 危重症患者肾替代治疗中不同抗凝策略的队列研究。
BMC Nephrol. 2020 Nov 16;21(1):486. doi: 10.1186/s12882-020-02150-8.
9
Deployment of a New CRRT/PIRRT Device during the COVID-19 Pandemic Emergency: Organizational Challenges and Implementation Results.COVID-19 大流行紧急情况下新型 CRRT/PIRRT 设备的部署:组织挑战和实施结果。
Blood Purif. 2021;50(3):390-398. doi: 10.1159/000511726. Epub 2020 Nov 10.
10
Cov-hep study: heparin in standard anticoagulation based on citrate for continuous veno-venous hemodialysis in patients with COVID-19: a structured summary of a study protocol for a randomized controlled trial.Cov-hep 研究:COVID-19 患者连续静脉-静脉血液透析中基于柠檬酸盐的标准抗凝方案中肝素的应用:一项随机对照试验研究方案的结构化总结。
Trials. 2020 Nov 11;21(1):920. doi: 10.1186/s13063-020-04814-0.

引用本文的文献

1
Efficacy and safety of low-molecular-weight-heparin plus citrate in nephrotic syndrome during continuous kidney replacement therapy: retrospective study.低分子量肝素联合枸橼酸盐在连续性肾脏替代治疗肾病综合征中的疗效及安全性:回顾性研究
PeerJ. 2025 Feb 25;13:e18919. doi: 10.7717/peerj.18919. eCollection 2025.
2
COVID-19 and Acute Kidney Injury.新型冠状病毒肺炎与急性肾损伤。
Crit Care Clin. 2022 Jul;38(3):473-489. doi: 10.1016/j.ccc.2022.01.002. Epub 2022 Jan 10.
3
COVID-19 and kidney disease: insights from epidemiology to inform clinical practice.

本文引用的文献

1
Acute kidney injury in patients hospitalized with COVID-19.COVID-19 住院患者中的急性肾损伤。
Kidney Int. 2020 Jul;98(1):209-218. doi: 10.1016/j.kint.2020.05.006. Epub 2020 May 16.
2
Coagulation abnormalities and thrombosis in patients with COVID-19.新型冠状病毒肺炎患者的凝血异常与血栓形成
Lancet Haematol. 2020 Jun;7(6):e438-e440. doi: 10.1016/S2352-3026(20)30145-9. Epub 2020 May 11.
3
High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study.严重严重急性呼吸综合征冠状病毒 2 型感染患者的血栓形成风险高:一项多中心前瞻性队列研究。
新型冠状病毒肺炎与肾脏疾病:从流行病学中获得的见解以指导临床实践
Nat Rev Nephrol. 2022 Aug;18(8):485-498. doi: 10.1038/s41581-022-00570-3. Epub 2022 Apr 13.
4
Acute kidney injury in patients hospitalized with COVID-19 from the ISARIC WHO CCP-UK Study: a prospective, multicentre cohort study.COVID-19 住院患者的急性肾损伤:一项前瞻性、多中心队列研究。
Nephrol Dial Transplant. 2022 Jan 25;37(2):271-284. doi: 10.1093/ndt/gfab303.
5
Experiences of Renal Replacement Therapy Delivery in Swedish Intensive Care Units during the COVID-19 Pandemic.瑞典重症监护病房在 COVID-19 大流行期间提供肾脏替代治疗的经验。
Blood Purif. 2022;51(7):584-589. doi: 10.1159/000519261. Epub 2021 Oct 6.
6
Application of extracorporeal therapies in critically ill COVID-19 patients.体外治疗在危重症 COVID-19 患者中的应用。
J Zhejiang Univ Sci B. 2021;22(9):701-717. doi: 10.1631/jzus.B2100344.
7
One Year on: An Overview of Singapore's Response to COVID-19-What We Did, How We Fared, How We Can Move Forward.一年回顾:新加坡应对 COVID-19 的概述——我们做了什么、表现如何、如何继续前进。
Int J Environ Res Public Health. 2021 Aug 30;18(17):9125. doi: 10.3390/ijerph18179125.
8
Kidney implications of SARS-CoV2 infection in children.儿童 SARS-CoV-2 感染的肾脏影响。
Pediatr Nephrol. 2022 Jul;37(7):1453-1467. doi: 10.1007/s00467-021-05249-8. Epub 2021 Aug 28.
9
Continuous renal replacement therapy in COVID-19-associated AKI: adding heparin to citrate to extend filter life-a retrospective cohort study.COVID-19 相关急性肾损伤的连续性肾脏替代治疗:在柠檬酸盐中添加肝素以延长滤器寿命——一项回顾性队列研究。
Crit Care. 2021 Aug 19;25(1):299. doi: 10.1186/s13054-021-03729-9.
10
Incidence and Outcomes of Acute Kidney Injury in COVID-19: A Systematic Review.新型冠状病毒肺炎相关急性肾损伤的发生率和结局:系统评价。
Blood Purif. 2022;51(3):199-212. doi: 10.1159/000514940. Epub 2021 Jun 15.
Intensive Care Med. 2020 Jun;46(6):1089-1098. doi: 10.1007/s00134-020-06062-x. Epub 2020 May 4.
4
Prevention and Treatment of Venous Thromboembolism Associated with Coronavirus Disease 2019 Infection: A Consensus Statement before Guidelines.新型冠状病毒病 2019 感染相关静脉血栓栓塞症的预防与治疗:指南出台前的共识声明。
Thromb Haemost. 2020 Jun;120(6):937-948. doi: 10.1055/s-0040-1710019. Epub 2020 Apr 21.
5
Incidence of thrombotic complications in critically ill ICU patients with COVID-19.COVID-19 重症监护病房危重症患者的血栓并发症发生率。
Thromb Res. 2020 Jul;191:145-147. doi: 10.1016/j.thromres.2020.04.013. Epub 2020 Apr 10.
6
COVID-19 and the Inpatient Dialysis Unit: Managing Resources during Contingency Planning Pre-Crisis.COVID-19与住院透析单元:危机前应急规划期间的资源管理
Clin J Am Soc Nephrol. 2020 May 7;15(5):720-722. doi: 10.2215/CJN.03750320. Epub 2020 Apr 3.
7
Clinical Characteristics of Coronavirus Disease 2019 in China.《中国 2019 年冠状病毒病临床特征》
N Engl J Med. 2020 Apr 30;382(18):1708-1720. doi: 10.1056/NEJMoa2002032. Epub 2020 Feb 28.
8
Accelerated Venovenous Hemofiltration as a Transitional Renal Replacement Therapy in the Intensive Care Unit.加速静脉-静脉血液滤过在重症监护病房作为过渡性肾脏替代治疗。
Am J Nephrol. 2020;51(4):318-326. doi: 10.1159/000506412. Epub 2020 Feb 25.
9
Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.《武汉 2019 年新型冠状病毒感染的肺炎 138 例住院患者临床特征分析》
JAMA. 2020 Mar 17;323(11):1061-1069. doi: 10.1001/jama.2020.1585.
10
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.中国武汉地区 2019 年新型冠状病毒感染患者的临床特征。
Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24.